ONCOassist vs PRESS calc
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ONCOassist
This app provides oncology professionals with a comprehensive suite of decision-support tools. It offers access to treatment protocols, survival rates, medical calculators, toxicity criteria, staging information, drug details, and news, all designed to aid in patient care and save time.
- NCCN Treatment Protocols
- Adjuvant Survival Rate Calculators
- Medical Formula Calculators
- CTCAE Toxicity Criteria
- AJCC TNM Staging
- Prognostic Scores
- Oncology Drug Information
- Drug Interaction Checker
Read full descriptionHide full description
Please note: This application, as a decision-support aid, is to be used by a practicing healthcare professional(“HCP”) and does not replace clinical judgement. It is not designed for use by patients and does not replace the advice of a doctor. ONCOassist is a comprehensive suite of decision support tools developed by oncology professionals, for oncology professionals. It includes a range of breakthrough tools designed to manage patient care effectively. Let's take a closer look at some of the features available: • NCCN Treatment Protocols: Developed in collaboration with the NCCN, this tool provides information on regimens taken from the NCCN template database. • Adjuvant Tools: These tools offer 5 and 10-year overall survival rates for patients with and without chemotherapy in an adjuvant setting. Breast cancer, colon cancer, and GIST tools are among the many adjuvant decision support tools available. • Useful formulas: Body Surface Area, Chemotherapy Dose Calculator, QTc, ECOG Performance Score, Khorana Score, MASCC Risk Index, and many more are included. These calculators simplify medical calculations and include frequently needed conversions and dosage calculations. • Common Toxicity Criteria for Adverse Events (CTCAE v4.0 & 5.0): This tool provides a standardized classification of adverse effects of drugs used in cancer therapy. CTCAE versions 5.0 and 4.0 are available in an easy-to-use and interactive format. • AJCC TNM staging: The tool provides criteria for every malignancy and includes the AJCC 7th, 8th, and 9th edition staging criteria. • Prognostic Scores: This tool offers over 17 prognostic scores for a range of specialties. It helps with prognostication, risk stratification, and determining eligibility for specific treatments or clinical trials. • Drug info section: Over 200 oncology drugs are available in an easy-to-use and interactive format. • Drug interaction checker: This tool helps users quickly check for potential drug interactions. • IO toxicity management tool: This tool is designed to manage immune-related adverse events. • ONCOnews: From breaking news to in-depth analysis, ONCOnews brings together all oncology news sources in one place. • ONCOvideos: This offers access to the most recent videos from Oncology Spotlight, which provides insights into the experiences of oncology professionals. Additionally, users can watch OncoAlert and Oncology Brother videos. ONCOassist offers oncology professionals the following benefits: Saves Time Oncology professionals no longer waste time searching through the internet for safe validated information to aid them with their decision making, all of the tools and information they need is available within ONCOassist and is available without the need for internet access. Improves quality of care ONCOassist promotes the use of evidence-based medicine. It is also the only CE approved oncology app on the market. Helps Empower Patients Adjuvant decision support tools contain patient-friendly information to allow for a more collaborative decision-making process. Regularly updating ONCOassist will be updated regularly with new prognostic tools and calculators. We will listen to your feedback and update accordingly. Email us at any time using feedback@oncoassist.com. ONCOassist is regulated by the Irish Health Products Regulatory Authority and is CE marked for conformance as a medical device.
PRESS calc
This medical tool estimates the probability of recovering oral intake or returning to a pre-stroke diet for individuals who have experienced an ischemic stroke. It is intended for use by healthcare professionals to aid in prognostication of dysphagia recovery.
- Predicts oral intake recovery probability
- Estimates return to pre-stroke diet
- Applicable to ischemic stroke patients
- For use by medical professionals
- Supports 7 and 30-day prognostication
Read full descriptionHide full description
PRESS (Predictive Swallowing Score) is a prediction tool applicable to people who suffered an ischaemic stroke leading to impaired oral intake. Given some clinical characteristics, it provides estimates of the probability to recover oral intake or return to prestroke diet 7 or 30 days after stroke. This tool is meant to be used only by medical professionals to improve prognostication of dysphagia recovery after stroke. Its clinical usefulness to influence medical decisions has not been tested.
Screenshots
Verdict
The clearest difference is review sentiment: ONCOassist at 100% against PRESS calc's 0%. ONCOassist also leads on rating (4.9 vs 1.0) and update cadence (every 10 days vs every 5 months). PRESS calc's advantage is ads (none vs shown) and monetization model (free vs free with in-app purchases). On price, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
ONCOassist holds the better App Store score, 4.9 against 1.0. That said, the two scores are not equally well evidenced: ONCOassist has 116 ratings behind it against 1, so its average is the more settled of the two. Written reviews point the same way: 100% of ONCOassist's written reviews are positive against 0% of PRESS calc's.
ONCOassist ships an update every 10 days, PRESS calc every 5 months. The most recent releases landed on November 1, 2026 and November 2, 2026 respectively.
| Parameter | ONCOassist | PRESS calc |
|---|---|---|
| Price | Free | Free |
| Rating | 4.9 (116 ratings) — better | 1.0 (1 ratings) |
| Positive reviews | 100.0% of reviews — better | 0.0% of reviews |
| Number of ratings | 116 — better | 1 |
| Update frequency | Every 10 days — better | Every 5 months |
| Ads | Yes | No — better |
| In-app purchases | No | No |
| Monetization | Free with in-app purchases | Free — better |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.6 | 13.0 — better |
| Further details — not scored | ||
| Size | 244 MB | 18 MB |
| Age rating | 17+ | 17+ |
| Developer | Portable Medical Technology Ltd | Marian Galovic |
Customer experience
ONCOassist
PRESS calc
Bugs and requests
ONCOassist
Requested features
3 requests- Radiation oncology topics
- Option in Spanish
- Russian language
PRESS calc
Not enough reviews yet to summarise bugs or requests.
In-app purchases
ONCOassist
No in-app purchases
PRESS calc
No in-app purchases









